ProCE Banner Activity

Clinical Implications on the Role of Novel Nonfactor Therapy to Improve Patient Outcomes


Downloadable slides from a live satellite symposium covering the latest safety and efficacy data on investigational nonfactor replacement therapies for the management of hemophilia.

Released: April 05, 2024

Expiration: April 04, 2025



Mark T. Reding

Mark T. Reding, MD

Professor of Medicine
Division of Hematology, Oncology, and Transplantation
Director, Center for Bleeding and Clotting Disorders
University of Minnesota Medical Center
Minneapolis, Minnesota

Provided by

Provided by Clinical Care Options, LLC.

ProCE Banner


Supported by an educational grant from Sanofi.